Throughout the given period , the percentage of in-house spending is expected to decrease from 66.3 percent in 2014 to almost 51 percent in 2023 . This statistic shows the percent distribution of in-house and outsourcing services expenditure in the global pharmaceutical market from 2014 to 2023 .
